Results 121 to 130 of about 11,283,677 (180)

The Pleiotropic Roles of Cytokines in Chimeric Antigen Receptor T-cell Therapy. [PDF]

Cancer Immunol Res
Stewart CM, Siegler EL, Kenderian SS.
europepmc   +1 more source

Chimeric antigen receptor (CAR) T-cell therapy for people with relapsed or refractory diffuse large B-cell lymphoma. [PDF]

Cochrane Database Syst Rev, 2021
Ernst M, Oeser A, Besiroglu B, Caro-Valenzuela J, Abd El Aziz M, Monsef I, Borchmann P, Estcourt LJ, Skoetz N, Goldkuhle M.   +9 more
europepmc   +1 more source

Differences and contributors to global cognitive performance in the underrepresented Latinx Parkinson's disease population. [PDF]

Clin Neuropsychol
Anis S, Chaparro-Solano HM, Peixoto Leal T, Sperling SA, Sonneborn C, Callegari Piccinin C, Inca-Martinez M, Cornejo-Olivas M, Illanes-Manrique M, Chana-Cuevas P, Safie Awad P, Jimena Hernández-Medrano A, Cervantes-Arriaga A, F S Schuh A, R M Rieder C, Braga-Neto P, Andrei da Silva Sena A, Lopes Santos-Lobato B, M Gatto E, J Alvarado G, L Avila C, Tumas V, Foss MP, Borges V, Ballalai Ferraz H, Luis Orozco Vélez J, Muñoz Ospina B, Moreno S, Pineda D, Esther Rios Pinto J, Olguín P, Cristobal Nuñez J, Viñuela A, O Espinal-Martinez A, Mori N, Mejía-Rojas K, Medina-Colque A, Lucia Zuma Rosso A, Vilaça C, Ochoa-Valle E, Cornejo-Herrera I, Reyes-Perez P, Lázaro-Figueroa A, Letícia de Moraes Alves A, Cury RG, Fernandez HH, Mata I, Latin American Research consortium on the Genetics of Parkinson’s Disease (LARGE-PD).   +47 more
europepmc   +1 more source

Evaluating the inhibitory effect of resveratrol on the multiplication of several Babesia species and Theileria equi on in vitro cultures, and Babesia microti in mice. [PDF]

Front Pharmacol, 2023
El-Sayed SAE, El-Alfy ES, Sayed-Ahmed MZ, Mohanta UK, Alqahtani SS, Alam N, Ahmad S, Ali MS, Igarashi I, Rizk MA.   +9 more
europepmc   +1 more source

SEOM-GOTEL clinical guidelines on diffuse large B-cell lymphoma (update 2025). [PDF]

Clin Transl Oncol
Gumà J, Palazón-Carrión N, Rueda-Domínguez A, Sequero S, Calvo V, García-Arroyo R, Gómez-Codina J, Llanos M, Martínez-Banaclocha N, Provencio M.   +9 more
europepmc   +1 more source

CAR T-cell product performance in haematological malignancies before and after marketing authorisation. [PDF]

Lancet Oncol, 2020
Elsallab M, Levine BL, Wayne AS, Abou-El-Enein M.   +3 more
europepmc   +1 more source

Incorporating mRNA therapeutics into biological treatments of hematologic malignancies. [PDF]

Front Immunol
Hunia J, Tomasik J, Czerwik N, Pezeshki PS, Nowis D.   +4 more
europepmc   +1 more source

Influence of Culture Conditions on Ex Vivo Expansion of T Lymphocytes and Their Function for Therapy: Current Insights and Open Questions. [PDF]

Front Bioeng Biotechnol, 2022
Sudarsanam H, Buhmann R, Henschler R.
europepmc   +1 more source

Enhancing CAR-T Efficacy in Large B-Cell Lymphoma with Radiation Bridging Therapy: A Real-World Single-Center Experience. [PDF]

Curr Oncol
Laverdure E, Mollica L, Ahmad I, Cohen S, Lachance S, Veilleux O, Bernard M, Marchand EL, Delisle JS, Bernard L, Boileau M, Petrella T, Pilon SJ, Bouchard P, Roy DC, Busque L, Fleury I.   +16 more
europepmc   +1 more source

Is Prophylaxis the Only Way Out for Cytokine Release Syndrome Associated With Chimeric Antigen T-cell Therapy? [PDF]

Cureus, 2021
Dave P, Pallares Vela E, Cancarevic I.
europepmc   +1 more source